Matches in SemOpenAlex for { <https://semopenalex.org/work/W92292034> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W92292034 endingPage "8" @default.
- W92292034 startingPage "S165" @default.
- W92292034 abstract "Producing effective therapeutic vaccines has proved much more difficult and challenging than developing cancer preventive vaccines. Despite huge research in the area of cancer immunology, FDA/EMEA have not approved any type of cancer treatment vaccine so far. More than 99% of cervical cancers have detectable amounts of human papillomavirus (HPV) DNA. Integration of high-risk HPV into the host cell genome is followed by continual expression of HPV E6 and E7 oncoproteins, making them excellent targets for developing vaccines which could be used in high grade precancerous (CIN) lesions or invasive cancer or in the prevention of cancer recurrence. Therapeutic cervical cancer vaccines have been extensively studied. Strategies used were vaccination with HPV peptides or proteins, alone or in pulsed dendritic cells, DNA vaccines, virus-like particles or viral and bacterial vectors. Lovaxin-C is a recombinant live-attenuated Listeria monocytogenes (Lm) that secretes the antigen HPV-16 E7 fused to a non-hemolytic listeriolysin O protein. In a phase I study Lovaxin-C was administered to advanced cervical cancer patients refractory to existing therapies. The dose-limiting toxicity was hypotension and flue-like syndrome. There were no serious adverse events. Specific T-cell response was detected as well as clinical response to Lovaxin-C. Several other therapeutic HPV vaccines are in clinical development and in most of the studies specific immunological and clinical responses were seen. Efficacious therapeutic vaccine for the treatment of cervical cancer should be expected in the near future." @default.
- W92292034 created "2016-06-24" @default.
- W92292034 creator A5002823367 @default.
- W92292034 creator A5011020309 @default.
- W92292034 creator A5018213904 @default.
- W92292034 creator A5026367636 @default.
- W92292034 creator A5041694396 @default.
- W92292034 creator A5070462646 @default.
- W92292034 creator A5072430373 @default.
- W92292034 creator A5089774924 @default.
- W92292034 date "2009-09-01" @default.
- W92292034 modified "2023-09-26" @default.
- W92292034 title "Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C." @default.
- W92292034 cites W1549035661 @default.
- W92292034 cites W1978699662 @default.
- W92292034 cites W1979514172 @default.
- W92292034 cites W1984569531 @default.
- W92292034 cites W1986176394 @default.
- W92292034 cites W1986847770 @default.
- W92292034 cites W1992512667 @default.
- W92292034 cites W1999263580 @default.
- W92292034 cites W2010848574 @default.
- W92292034 cites W2019740915 @default.
- W92292034 cites W2047138171 @default.
- W92292034 cites W2102632609 @default.
- W92292034 cites W2141143434 @default.
- W92292034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19785060" @default.
- W92292034 hasPublicationYear "2009" @default.
- W92292034 type Work @default.
- W92292034 sameAs 92292034 @default.
- W92292034 citedByCount "9" @default.
- W92292034 countsByYear W922920342013 @default.
- W92292034 countsByYear W922920342014 @default.
- W92292034 countsByYear W922920342015 @default.
- W92292034 countsByYear W922920342016 @default.
- W92292034 countsByYear W922920342017 @default.
- W92292034 countsByYear W922920342019 @default.
- W92292034 countsByYear W922920342021 @default.
- W92292034 crossrefType "journal-article" @default.
- W92292034 hasAuthorship W92292034A5002823367 @default.
- W92292034 hasAuthorship W92292034A5011020309 @default.
- W92292034 hasAuthorship W92292034A5018213904 @default.
- W92292034 hasAuthorship W92292034A5026367636 @default.
- W92292034 hasAuthorship W92292034A5041694396 @default.
- W92292034 hasAuthorship W92292034A5070462646 @default.
- W92292034 hasAuthorship W92292034A5072430373 @default.
- W92292034 hasAuthorship W92292034A5089774924 @default.
- W92292034 hasConcept C121608353 @default.
- W92292034 hasConcept C126322002 @default.
- W92292034 hasConcept C143998085 @default.
- W92292034 hasConcept C147483822 @default.
- W92292034 hasConcept C159047783 @default.
- W92292034 hasConcept C167508917 @default.
- W92292034 hasConcept C203014093 @default.
- W92292034 hasConcept C22070199 @default.
- W92292034 hasConcept C2777701055 @default.
- W92292034 hasConcept C2778220009 @default.
- W92292034 hasConcept C2778378633 @default.
- W92292034 hasConcept C2778580637 @default.
- W92292034 hasConcept C2780009117 @default.
- W92292034 hasConcept C2780801004 @default.
- W92292034 hasConcept C502942594 @default.
- W92292034 hasConcept C71924100 @default.
- W92292034 hasConceptScore W92292034C121608353 @default.
- W92292034 hasConceptScore W92292034C126322002 @default.
- W92292034 hasConceptScore W92292034C143998085 @default.
- W92292034 hasConceptScore W92292034C147483822 @default.
- W92292034 hasConceptScore W92292034C159047783 @default.
- W92292034 hasConceptScore W92292034C167508917 @default.
- W92292034 hasConceptScore W92292034C203014093 @default.
- W92292034 hasConceptScore W92292034C22070199 @default.
- W92292034 hasConceptScore W92292034C2777701055 @default.
- W92292034 hasConceptScore W92292034C2778220009 @default.
- W92292034 hasConceptScore W92292034C2778378633 @default.
- W92292034 hasConceptScore W92292034C2778580637 @default.
- W92292034 hasConceptScore W92292034C2780009117 @default.
- W92292034 hasConceptScore W92292034C2780801004 @default.
- W92292034 hasConceptScore W92292034C502942594 @default.
- W92292034 hasConceptScore W92292034C71924100 @default.
- W92292034 hasLocation W922920341 @default.
- W92292034 hasOpenAccess W92292034 @default.
- W92292034 hasPrimaryLocation W922920341 @default.
- W92292034 hasRelatedWork W1572175794 @default.
- W92292034 hasRelatedWork W2015138985 @default.
- W92292034 hasRelatedWork W2028029981 @default.
- W92292034 hasRelatedWork W2052143612 @default.
- W92292034 hasRelatedWork W2086695199 @default.
- W92292034 hasRelatedWork W2102632609 @default.
- W92292034 hasRelatedWork W2193889148 @default.
- W92292034 hasRelatedWork W92292034 @default.
- W92292034 hasRelatedWork W125226333 @default.
- W92292034 hasRelatedWork W2739626200 @default.
- W92292034 hasVolume "14 Suppl 1" @default.
- W92292034 isParatext "false" @default.
- W92292034 isRetracted "false" @default.
- W92292034 magId "92292034" @default.
- W92292034 workType "article" @default.